Sophia Genetics Partners with Swift Biosciences Thursday, February 11, 2016 Sophia Genetics launches a new combined genetic test solution in Europe by combining Swift Biosciences Accel-Amplicon™ panels with Sophia DDM™, the company’s analytics platform for molecular diagnosis.Silicon Biosystems, Swift Announce Collaboration Thursday, February 11, 2016 Silicon Biosystems and Swift Biosciences have announced a scientific collaboration and co-marketing partnership aimed at enabling translational researchers to obtain high-quality sequencing results from as few as a couple hundred tumor and normal cells in an optimized and seamless work¬flow. Genomics England, Illumina Enter Bioinformatics Partnership Thursday, February 11, 2016 Illumina, and Genomics England have announced a partnership to develop a platform and knowledge base that can be used to improve and automate genome interpretation. PathoQuest Announces New Leadership at the Board of Directors Tuesday, February 09, 2016 Company has announced new leadership for transformation of edge technology platform to a commercial organization.TATAA Biocenter, Yikon Partner Tuesday, February 09, 2016 TATAA Biocenter and Yikon Genomics has Announced Strategic Partnership to distribute Yikon’s MALBACTM products for single cell profiling and YK-PGSTM Solutions in Europe.DNAnexus, Sapio Collaborate Thursday, February 04, 2016 DNAnexus Inc., the global leader in cloud-based genome informatics and data management, has announced the integration of its cloud-based genomics platform with Sapio Sciences’ Exemplar Next Generation Sequencing (NGS) Laboratory Information Management System (LIMS) solution for clinical and research labs. Illumina Signs Multiple Biobank Deals Wednesday, February 03, 2016 MEGA array family and next-generation sequencing to support comprehensive genomics approach toward personalized medicine.
Swift Biosciences, SeraCare Partner Monday, February 01, 2016 Swift Biosciences and SeraCare Life Sciences have announced a partnership to accelerate development of a novel circulating tumor DNA reference material. Venaxis Announces Transaction with Strand Life Sciences Thursday, January 28, 2016 Venaxis®, Inc. has announced that it has entered into a series of agreements for a transaction with Strand Life Sciences Private Limited (Strand LS) and its shareholders.